By Sarah Mirando  |  July 9, 2013

Category: Pharmaceuticals
Follow us on Twitter and Facebook for the latest Januvia/Byetta Class Action Lawsuit & Settlement News!

 

New Byetta/Januvia Pancreatic Cancer Death Lawsuit Filed in Florida

By  John Curran

 

Januvia, Byetta pancreatic cancer deathA widow whose husband died from pancreatic cancer has filed a lawsuit against the makers of his diabetes medications, Januvia and Byetta, alleging that the drugs directly contributed to his cancer and death. She is seeking damages from Merck, Amylin Pharmaceuticals and Eli Lilly and Company.

Plaintiff Denise Alesi alleges in the Januvia cancer lawsuit that her husband Andrew Alesi was diagnosed with type-2 diabetes and began taking the Januvia and Byetta in September 2009. Roughly two years later was diagnosed with pancreatic cancer – a proven side effect of Januvia and Byetta – that proved fatal. The case may soon be added to the Januvia cancer lawsuit MDL known as In re: Incretin Mimetics Product Liability Litigation.

Hundreds of product liability lawsuits and wrongful death lawsuits have been filed regarding the two type-2 diabetes drugs. Some, like Alesi’s lawsuit, cite studies and medical research that plaintiffs say prove the drug makers had seen evidence of the potential risk of pancreatic cancer from Januvia and Byetta, but failed to warn consumers. In the case of Byetta, the risk of pancreatic cancer is nearly three times higher than those of other type-2 diabetes treatments. In addition, reports of thyroid cancer linked to Byetta and Januvia have also been increasing.

Many of the problems reported by patients leading to these Januvia and Byetta side effects result from the same issue: due to increased insulin resistance, these medications are designed to increase pancreatic tissue. Doing so may cause pancreatitis, a precursor to cancer, as well as disrupt the function of the thyroid, which can lead to medical problems.

Alesi is seeking damages of more than $75,000 from the three drug companies as the personal representative of the estate of her husband.

The Byetta/Januvia Cancer Lawsuit case is Alesi v. Merck Sharp & Dohme Corp., et al., Case No. 13-cv-00292, in the U.S. District Court for the District of New Jersey.

If you took a type-2 diabetes drug like Januvia or Byetta and developed thyroid cancer or pancreatic cancer, you have legal options. The first step is getting a free consultation with a Januvia lawsuit attorney, and one is available by filling out the short form at the Type 2 Diabetes Drugs Januvia, Byetta Class Action Lawsuit Investigation. As cases move toward consolidation and then trial, it is important to act quickly so there is no delay in any potential legal remedies the facts of your case merit.

We tell you about cash you can claim EVERY WEEK! Sign up for our free newsletter.

 

Updated July 9th, 2013

 

All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.

 

LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2013 Top Class Actions® LLC
Various Trademarks held by their respective owners.

Leave a Reply

Your email address will not be published. By submitting your comment and contact information, you agree to receive marketing emails from Top Class Actions regarding this and/or similar lawsuits or settlements, and/or to be contacted by an attorney or law firm to discuss the details of your potential case at no charge to you if you qualify. Required fields are marked *

Please note: Top Class Actions is not a settlement administrator or law firm. Top Class Actions is a legal news source that reports on class action lawsuits, class action settlements, drug injury lawsuits and product liability lawsuits. Top Class Actions does not process claims and we cannot advise you on the status of any class action settlement claim. You must contact the settlement administrator or your attorney for any updates regarding your claim status, claim form or questions about when payments are expected to be mailed out.